Celgene Corporation Contingent Value Rights
CELGZ
CELGZ was delisted on the 29th of November, 2019.
19 hedge funds and large institutions have $415K invested in Celgene Corporation Contingent Value Rights in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
34% more capital invested
Capital invested by funds: $311K → $415K (+$104K)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
10% less funds holding
Funds holding: 21 → 19 (-2)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DAM
Deltec Asset Management
New York
|
+$31.2K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$5.33K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$3 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$12K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$2.43K |
| 3 |
FA
FCG Advisors
Chatham,
New Jersey
|
-$339 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CC
1
Cannell & Co
New York
| $135K | – | – | – |
|
|
BC
2
Birchview Capital
Burlington,
Vermont
| $98K | – | – | – |
|
|
FA
3
FCG Advisors
Chatham,
New Jersey
| $72K | -$339 | -1,126 | -0.6% |
|
|
DC
4
Davenport & Co
Richmond,
Virginia
| $43K | – | – | – |
|
|
DAM
5
Deltec Asset Management
New York
| $38K | +$31.2K | +103,646 | New |
|
|
6
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $11K | +$5.33K | +17,715 | +131% |
|
7
California Public Employees Retirement System
Sacramento,
California
| $6K | – | – | – |
|
|
BFA
8
Beaumont Financial Advisors
Needham,
Massachusetts
| $5K | – | – | – |
|
9
Bank of America
Charlotte,
North Carolina
| $3K | – | – | – |
|
10
First Manhattan
New York
| $2K | – | – | – |
|
|
BWM
11
Baystate Wealth Management
Boston,
Massachusetts
| $1K | – | – | – |
|
12
Morgan Stanley
New York
| $1K | – | – | – |
|
|
13
Citadel Advisors
Miami,
Florida
| – | -$12K | -32,480 | Closed |
|
|
14
UBS Group
Zurich,
Switzerland
| – | -$2.43K | -8,087 | -88% |
|
|
15
Wells Fargo
San Francisco,
California
| – | +$3 | +9 | +2% |
|
CELGZ Hedge Fund Activity: Q2 2018 in Review
19 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Celgene Corporation Contingent Value Rights (CELGZ) for Q2 2018, worth a combined $415K — up 34% from $311K a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of CELGZ and 1 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 2 added.
The largest buyer was Deltec Asset Management, opening a new position worth an estimated $31.2K. The largest seller was Citadel Advisors, exiting entirely with an estimated $12K sold.
- 19 institutional investors held Celgene Corporation Contingent Value Rights (CELGZ) as of Q2 2018, down from 21 in Q1 2018.
- Funds reported $415K of Celgene Corporation Contingent Value Rights stock for Q2 2018, up 34% quarter-over-quarter.
- 1 fund opened new Celgene Corporation Contingent Value Rights positions in Q2 2018 and 2 closed out, a net change of -1 holder.
- The largest Celgene Corporation Contingent Value Rights buyer in Q2 2018 was Deltec Asset Management, an estimated $31.2K added.
- The largest Celgene Corporation Contingent Value Rights seller in Q2 2018 was Citadel Advisors, an estimated $12K sold.
Based on aggregated 13F filings for Q2 2018.